|
US4309989A
(en)
|
1976-02-09 |
1982-01-12 |
The Curators Of The University Of Missouri |
Topical application of medication by ultrasound with coupling agent
|
|
GB2097032B
(en)
|
1981-04-22 |
1984-09-19 |
Teron International Urban Dev |
A combined ceiling air and services distribution system mechanical chasse and structural roof member
|
|
US4656134A
(en)
|
1982-01-11 |
1987-04-07 |
Board Of Trustees Of Leland Stanford Jr. University |
Gene amplification in eukaryotic cells
|
|
US4818542A
(en)
|
1983-11-14 |
1989-04-04 |
The University Of Kentucky Research Foundation |
Porous microspheres for drug delivery and methods for making same
|
|
US5168062A
(en)
|
1985-01-30 |
1992-12-01 |
University Of Iowa Research Foundation |
Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence
|
|
US4683202A
(en)
|
1985-03-28 |
1987-07-28 |
Cetus Corporation |
Process for amplifying nucleic acid sequences
|
|
US4965188A
(en)
|
1986-08-22 |
1990-10-23 |
Cetus Corporation |
Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
|
|
US4683195A
(en)
|
1986-01-30 |
1987-07-28 |
Cetus Corporation |
Process for amplifying, detecting, and/or-cloning nucleic acid sequences
|
|
US4766067A
(en)
|
1985-05-31 |
1988-08-23 |
President And Fellows Of Harvard College |
Gene amplification
|
|
US5618920A
(en)
|
1985-11-01 |
1997-04-08 |
Xoma Corporation |
Modular assembly of antibody genes, antibodies prepared thereby and use
|
|
US5576195A
(en)
|
1985-11-01 |
1996-11-19 |
Xoma Corporation |
Vectors with pectate lyase signal sequence
|
|
GB8601597D0
(en)
|
1986-01-23 |
1986-02-26 |
Wilson R H |
Nucleotide sequences
|
|
US4800159A
(en)
|
1986-02-07 |
1989-01-24 |
Cetus Corporation |
Process for amplifying, detecting, and/or cloning nucleic acid sequences
|
|
US4767402A
(en)
|
1986-07-08 |
1988-08-30 |
Massachusetts Institute Of Technology |
Ultrasound enhancement of transdermal drug delivery
|
|
US4889818A
(en)
|
1986-08-22 |
1989-12-26 |
Cetus Corporation |
Purified thermostable enzyme
|
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
|
US4704692A
(en)
|
1986-09-02 |
1987-11-03 |
Ladner Robert C |
Computer based system and method for determining and displaying possible chemical structures for converting double- or multiple-chain polypeptides to single-chain polypeptides
|
|
US5260203A
(en)
|
1986-09-02 |
1993-11-09 |
Enzon, Inc. |
Single polypeptide chain binding molecules
|
|
US4795699A
(en)
|
1987-01-14 |
1989-01-03 |
President And Fellows Of Harvard College |
T7 DNA polymerase
|
|
US4921794A
(en)
|
1987-01-14 |
1990-05-01 |
President And Fellows Of Harvard College |
T7 DNA polymerase
|
|
US4939666A
(en)
|
1987-09-02 |
1990-07-03 |
Genex Corporation |
Incremental macromolecule construction methods
|
|
US5130238A
(en)
|
1988-06-24 |
1992-07-14 |
Cangene Corporation |
Enhanced nucleic acid amplification process
|
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
|
US5142033A
(en)
|
1988-09-23 |
1992-08-25 |
Hoffmann-La Roche Inc. |
Structure-independent DNA amplification by the polymerase chain reaction
|
|
US5091310A
(en)
|
1988-09-23 |
1992-02-25 |
Cetus Corporation |
Structure-independent dna amplification by the polymerase chain reaction
|
|
US5066584A
(en)
|
1988-09-23 |
1991-11-19 |
Cetus Corporation |
Methods for generating single stranded dna by the polymerase chain reaction
|
|
US4994370A
(en)
|
1989-01-03 |
1991-02-19 |
The United States Of America As Represented By The Department Of Health And Human Services |
DNA amplification technique
|
|
US5266491A
(en)
|
1989-03-14 |
1993-11-30 |
Mochida Pharmaceutical Co., Ltd. |
DNA fragment and expression plasmid containing the DNA fragment
|
|
AU638762B2
(en)
|
1989-10-05 |
1993-07-08 |
Optein Inc |
Cell-free synthesis and isolation of novel genes and polypeptides
|
|
US5427908A
(en)
|
1990-05-01 |
1995-06-27 |
Affymax Technologies N.V. |
Recombinant library screening methods
|
|
DK0600866T3
(da)
|
1990-06-01 |
1998-03-09 |
Chiron Corp |
Præparater og fremgangsmåder til identifikation af biologisk aktive molekyler
|
|
US5723286A
(en)
|
1990-06-20 |
1998-03-03 |
Affymax Technologies N.V. |
Peptide library and screening systems
|
|
US5580734A
(en)
|
1990-07-13 |
1996-12-03 |
Transkaryotic Therapies, Inc. |
Method of producing a physical map contigous DNA sequences
|
|
WO1992005258A1
(en)
|
1990-09-20 |
1992-04-02 |
La Trobe University |
Gene encoding barley enzyme
|
|
CA2095633C
(en)
|
1990-12-03 |
2003-02-04 |
Lisa J. Garrard |
Enrichment method for variant proteins with altered binding properties
|
|
JPH06508022A
(ja)
|
1991-02-21 |
1994-09-14 |
ギリアド サイエンシズ，インコーポレイテッド |
生体分子に特異的なアプタマーおよび生産方法
|
|
US5270170A
(en)
|
1991-10-16 |
1993-12-14 |
Affymax Technologies N.V. |
Peptide library and screening method
|
|
US5641670A
(en)
|
1991-11-05 |
1997-06-24 |
Transkaryotic Therapies, Inc. |
Protein production and protein delivery
|
|
US5733761A
(en)
|
1991-11-05 |
1998-03-31 |
Transkaryotic Therapies, Inc. |
Protein production and protein delivery
|
|
PT1024191E
(pt)
|
1991-12-02 |
2008-12-22 |
Medical Res Council |
Produção de auto-anticorpos a partir de reportórios de segmentos de anticorpo e exibidos em fagos
|
|
US5643252A
(en)
|
1992-10-28 |
1997-07-01 |
Venisect, Inc. |
Laser perforator
|
|
WO1994012520A1
(en)
|
1992-11-20 |
1994-06-09 |
Enzon, Inc. |
Linker for linked fusion polypeptides
|
|
US5763733A
(en)
|
1994-10-13 |
1998-06-09 |
Enzon, Inc. |
Antigen-binding fusion proteins
|
|
US5549551A
(en)
|
1994-12-22 |
1996-08-27 |
Advanced Cardiovascular Systems, Inc. |
Adjustable length balloon catheter
|
|
US5656730A
(en)
|
1995-04-07 |
1997-08-12 |
Enzon, Inc. |
Stabilized monomeric protein compositions
|
|
US6019968A
(en)
|
1995-04-14 |
2000-02-01 |
Inhale Therapeutic Systems, Inc. |
Dispersible antibody compositions and methods for their preparation and use
|
|
US5730723A
(en)
|
1995-10-10 |
1998-03-24 |
Visionary Medical Products Corporation, Inc. |
Gas pressured needle-less injection device and method
|
|
IL120943A
(en)
|
1997-05-29 |
2004-03-28 |
Univ Ben Gurion |
A system for administering drugs through the skin
|
|
AU756693B2
(en)
|
1997-09-29 |
2003-01-23 |
Novartis Ag |
Stabilized bioactive preparations and methods of use
|
|
JP2003135078A
(ja)
*
|
2001-07-26 |
2003-05-13 |
Japan Tobacco Inc |
Ｃ型肝炎ウイルスｎｓ５ａタンパク質の変異体、およびその利用
|
|
WO2005063170A2
(en)
*
|
2003-12-29 |
2005-07-14 |
Toudai Tlo, Ltd. |
Methods of identifying immunoregulatory agents, immunoregulatory agents, and uses thereof
|
|
WO2006133398A2
(en)
|
2005-06-08 |
2006-12-14 |
Invitrogen Corporation |
In vitro activated donor t-cells to promote transplant engraftment
|
|
EP2160461B1
(en)
|
2007-07-04 |
2012-08-08 |
Max-Delbrück-Centrum für Molekulare Medizin (MDC) |
Hyperactive variants of the transposase protein of the transposon system sleeping beauty
|
|
WO2010126766A1
(en)
|
2009-04-30 |
2010-11-04 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Inducible interleukin-12
|
|
FR2952374B1
(fr)
*
|
2009-11-06 |
2012-11-16 |
Univ Claude Bernard Lyon |
Production de facteur ix recombinant dans une lignee cellulaire hepatocytaire humaine
|
|
US9089520B2
(en)
|
2010-05-21 |
2015-07-28 |
Baylor College Of Medicine |
Methods for inducing selective apoptosis
|
|
JP6440496B2
(ja)
|
2011-09-27 |
2018-12-19 |
ヤンセン バイオテツク，インコーポレーテツド |
選択的結合表面を有するフィブロネクチンｉｉｉ型反復ベースのタンパク質スカフォールド
|
|
MX367100B
(es)
*
|
2012-02-17 |
2019-08-05 |
The Children´S Hospital Of Philadelphia |
Composiciones del vector aav y metodos para su transferencia genetica a celulas, organos y tejidos.
|
|
ES2791598T3
(es)
|
2013-06-05 |
2020-11-05 |
Bellicum Pharmaceuticals Inc |
Métodos para inducir apoptosis parcial utilizando polipéptidos de caspasa
|
|
KR102375998B1
(ko)
|
2014-02-14 |
2022-03-21 |
더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 |
키메라 항원 수용체 및 제조방법
|
|
US10344285B2
(en)
|
2014-04-09 |
2019-07-09 |
Dna2.0, Inc. |
DNA vectors, transposons and transposases for eukaryotic genome modification
|
|
CN107810420B
(zh)
*
|
2015-06-25 |
2020-08-14 |
豪夫迈·罗氏有限公司 |
用于测定抗体或配体结合和功能的基于细胞的测定
|
|
GB2592821B
(en)
|
2015-07-31 |
2022-01-12 |
Univ Minnesota |
Modified cells and methods of therapy
|
|
GB201514875D0
(en)
*
|
2015-08-20 |
2015-10-07 |
Autolus Ltd |
Receptor
|
|
WO2017133175A1
(en)
*
|
2016-02-04 |
2017-08-10 |
Nanjing Legend Biotech Co., Ltd. |
Engineered mammalian cells for cancer therapy
|
|
CN109312361A
(zh)
|
2016-02-26 |
2019-02-05 |
波赛伊达治疗学股份有限公司 |
转座子系统及应用方法
|
|
WO2018073394A1
(en)
*
|
2016-10-19 |
2018-04-26 |
Cellectis |
Cell death inducing chimeric antigen receptors
|
|
CN118374493A
(zh)
|
2017-05-17 |
2024-07-23 |
西雅图儿童医院（Dba西雅图儿童研究所） |
生成哺乳动物t细胞活化诱导型合成启动子(syn+pro)以改善t细胞疗法
|
|
WO2019014390A1
(en)
|
2017-07-12 |
2019-01-17 |
Refuge Biotechnologies, Inc. |
METHODS AND SYSTEMS FOR CONDITIONAL REGULATION OF GENE EXPRESSION
|
|
AU2018329741B2
(en)
|
2017-09-08 |
2025-02-20 |
Poseida Therapeutics, Inc. |
Compositions and methods for chimeric ligand receptor (CLR)-mediated conditional gene expression
|
|
AU2019335014A1
(en)
|
2018-09-05 |
2021-03-25 |
Poseida Therapeutics, Inc. |
Allogeneic cell compositions and methods of use
|